Media Mentions
2008
Frank Schoneveld and Marc Sorini were quoted in the May 20 issue of Managing Intellectual Property in an article discussing the regulatory issues that alcohol manufacturers and distributors face when importing their product into the European Union and United States. Mr. Sorini said that while many people regard the U.S. as one of the most open economies in the world, when it comes to alcohol, "The regulatory system is more complicated, more expensive and more time consuming than you could have possibly imagined." Mr. Schoneveld advised people not only to register trade marks, but also to look at getting additional protection such as protected designation, traditional specialty guaranteed and, if possible, protected geographical indication.
Frank Schoneveld, Marc E. Sorini, Alcohol Beverages & Products, Brussels, EU Regulatory, Intellectual Property - Alcohol Beverages & Products
2007
Clive Stanbrook was quoted in the April 27 issue of The Wall Street Journal on the European Union's (EU) increased fines on cartel enforcement. "The EU can keep raising fines to fight cartels, but their tools are less sophisticated than those used in the United States," commented Mr. Stanbrook.
Clive Stanbrook QC, Brussels, EU Regulatory, International Trade - Brussels
2006
Clive Stanbrook was quoted in the April 7 issue of The Wall Street Journal regarding the decision by the EU to broaden the offensive against "golden shares." Clive commented that the use of so-called poison pills, shareholder-rights plans that were first deployed in the United States during the 1980s to make hostile takeovers prohibitively expensive, have been limited by judges.
Clive Stanbrook QC, Antitrust & Competition, Brussels, EU Competition, EU Regulatory
Clive Stanbrook QC was quoted in the 17 March issue of Competition Law360. The Brussels office partners were interviewed for a special series on law firms in Brussels, beginning with a feature on McDermott Will & Emery/Stanbrook LLP.
Clive Stanbrook QC, Antitrust & Competition, Brussels, EU Competition, EU Regulatory
Frank Schoneveld was interviewed on 10 February by LexisNexis regarding the impact on drug firms of paediatric product regulation.
Frank Schoneveld, Brussels, EU Regulatory, Product Liability
2005
Clive Stanbrook commented on Bloomberg.com on June 3 regarding an investigation by the European Commission.
Clive Stanbrook QC, Antitrust & Competition, Brussels, EU Regulatory
